Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Market Cap	7.01B -18.2%
Revenue (ttm)	33.60B +3.0%
Net Income	675.86M +40.2%
EPS	0.18 +41.6%
Shares Out	n/a
PE Ratio	10.37
Forward PE	11.35
Dividend	0.05 (3.94%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	n/a
Open	1.250
Previous Close	1.220
Day's Range	1.250 - 1.250
52-Week Range	1.160 - 1.500
Beta	n/a
RSI	50.56
Earnings Date	Mar 31, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 49,402
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S1R

Financial Performance

In 2024, FRA:S1R's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY